MTrap Overview
- Year Founded
-
2014
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
MTrap General Information
Description
Developer of novel therapeutic devices intended to treat a new disruptive approach to cancer treatment. The company's devices interfere with the intense dialogue and crosstalk between the primary tumor and the microenvironment and represent a new disruptive approach to cancer treatment, enabling physicians to treat their patients in an enhanced way.
Contact Information
Website
www.m-trap.comCorporate Office
- 177 Main Street
- Suite 202
- Huntington, NY 11743
- United States
Corporate Office
- 177 Main Street
- Suite 202
- Huntington, NY 11743
- United States
MTrap Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 31-Dec-2019 | Completed | Out of Business | |||
| 1. Early Stage VC (Series A) | 15-Jun-2016 | Completed | Generating Revenue |
MTrap Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
MTrap FAQs
-
When was MTrap founded?
MTrap was founded in 2014.
-
Where is MTrap headquartered?
MTrap is headquartered in Huntington, NY.
-
What industry is MTrap in?
MTrap’s primary industry is Therapeutic Devices.
-
Is MTrap a private or public company?
MTrap is a Private company.
-
What is MTrap’s current revenue?
The current revenue for MTrap is .
-
How much funding has MTrap raised over time?
MTrap has raised $6M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process